SOLV — Solventum Corporation
$85.41-2.33%
Last close: · regular session
Last 60 sessions
SOLV closed at $85.41 (-2.33%) on Oct 23, 2026. Active automatic shelf (S-3ASR, Aug 2025). Float: 147.3M shares. Latest SEC filing: 8-K on Jul 20, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for SOLV in the TickerWise workspace.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Company profile
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: US
- Exchange: NYSE
- Employees: 22,000
- Website: https://www.solventum.com
Latest SEC filings for SOLV
Latest SOLV news
- SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy Read article
- Solventum collecting offers for Health Information Systems Business - Axios Pro Read article
- Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? Read article
- Why Solventum (SOLV) is a Top Value Stock for the Long-Term Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.